Summary
A surge in monsoon illnesses and H1N1 cases is significantly boosting demand for acute therapies and flu vaccines. This has led to a 12% month-on-month increase in anti-infective and antibacterial sales in July, and nearly tripled flu vaccine sales year-on-year in August, causing supply challenges in several cities.